医療用転写ソフトウェアのグローバル市場(2021〜2031):クラウドベース、オンプレミス

■ 英語タイトル:Medical Transcription Software Market By Deployment (Cloud Based, On Premises), By Type (Voice Capture, Voice Recognition), By End User Facilities (Hospitals and Clinics, Diagnostic Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

調査会社Allied Market Research社が発行したリサーチレポート(データ管理コード:ALD23FB264)■ 発行会社/調査会社:Allied Market Research
■ 商品コード:ALD23FB264
■ 発行日:2022年10月
■ 調査対象地域:グローバル
■ 産業分野:医療
■ ページ数:254
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後24時間以内)
■ 販売価格オプション(消費税別)
Online Only(1名閲覧、印刷不可)USD3,570 ⇒換算¥542,640見積依頼/購入/質問フォーム
Single User(1名閲覧)USD5,730 ⇒換算¥870,960見積依頼/購入/質問フォーム
Enterprise User(閲覧人数無制限)USD9,600 ⇒換算¥1,459,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Allied Market Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[医療用転写ソフトウェアのグローバル市場(2021〜2031):クラウドベース、オンプレミス]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Allied Market Research社の本市場調査レポートでは、2021年に1,631.74百万ドルであった世界の医療用転写ソフトウェア市場規模が、2031年までに7,001.68百万ドルに到達し、2022年から2031年にかけてCAGR(年平均成長率)15.5%で成長すると予測しています。本レポートは、医療用転写ソフトウェアの世界市場を総合的に調査・分析した資料であり、イントロダクション、エグゼクティブサマリー、市場概要、展開別(クラウドベース、オンプレミス)分析、種類別(音声保存、音声認識)分析、エンドユーザー別(病院・診療所、診断センター、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ)分析、企業状況、企業情報などを掲載しています。また、本レポートは、3M Company、Amazon Inc、Aquity Solutions、DeepScribe, Inc.、Dolbey System, Inc.、Global Medical Transcription、iMedX、Microsoft Corporation、SMARTMD、ZyDoc Medical Transcriptionなどの企業情報を含んでいます。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界の医療用転写ソフトウェア市場規模:展開別
- クラウドベース医療用転写ソフトウェアの市場規模
- オンプレミス医療用転写ソフトウェアの市場規模
・世界の医療用転写ソフトウェア市場規模:種類別
- 音声保存における市場規模
- 音声認識における市場規模
・世界の医療用転写ソフトウェア市場規模:エンドユーザー別
- 病院・診療所における市場規模
- 診断センターにおける市場規模
- その他における市場規模
・世界の医療用転写ソフトウェア市場規模:地域別
- 北米の医療用転写ソフトウェア市場規模
- ヨーロッパの医療用転写ソフトウェア市場規模
- アジア太平洋の医療用転写ソフトウェア市場規模
- 中南米・中東・アフリカの医療用転写ソフトウェア市場規模
・企業状況
・企業情報

医療用転写ソフトウェアの世界市場は、2021年に16億3,174万ドルと評価され、2022年から2031年までの年平均成長率は15.5%となり、2031年には70億1,168万ドルに達すると予測されています。

医療トランスクリプションはMTとも呼ばれ、医師や看護師、その他の医療従事者が口述した音声記録された医療報告書を書き写すプロセスを扱う医療関連専門職です。医療報告書には、音声ファイル、講義中のメモ、その他の音声資料が含まれます。これらは電話で口述されるか、インターネットやスマートフォンアプリを通じてデジタルでアップロードされます。
デジタル文書作成のための医療用転写ソフトウェアの採用の増加、クラウドベースの医療用転写ソフトウェアの使用の増加、高齢化人口の急増、それに伴う慢性疾患数の増加が市場成長の原動力となっています。しかし、新興市場における医療ITインフラの不足、人材育成などソフトウェア導入に関連する問題、患者データの安全性とセキュリティに関する懸念の高まりなどが、市場成長の妨げになると予想されます。さらに、発展途上地域における巨大な市場ポテンシャルは、予測期間中に市場成長の機会を提供すると期待されています。

医療用転写ソフトウェア市場は、展開、種類、エンドユーザー施設、地域に区分されます。展開別では、市場はクラウドベースとオンプレミスに分類されます。種類別では、音声キャプチャと音声認識に分類されます。エンドユーザー施設別では、市場は病院・診療所、診断センター、その他に分類されます。その他には、外来手術センターやヘルスケアシステムが含まれ、病院・診療所はさらに私立と公立に区分されます。地域別では、北米(米国、カナダ、メキシコ)、欧州(ドイツ、フランス、英国、イタリア、スペイン、欧州のその他地域)、アジア太平洋(日本、中国、オーストラリア、インド、韓国、アジア太平洋のその他地域)、LAMEA(ブラジル、南アフリカ、サウジアラビア、LAMEAのその他地域)に市場を分けて分析しています。

世界の医療転写ソフトウェア市場で事業を展開する主な主要プレーヤーは、3M、Dolbey System, Inc.、Global Medical Transcription、DeepScribe, Inc.、Microsoft Corporation (Nuance Communication, Inc.)、Amazon, Inc.です。

〈ステークホルダーにとっての主なメリット〉
・本レポートは、2021年から2031年までの医療用転写ソフトウェア市場分析の市場セグメント、現在の動向、予測、ダイナミクスを定量的に分析し、医療用転写ソフトウェア市場の有力な機会を特定します。
・主な促進要因、阻害要因、機会に関する情報とともに市場調査を提供します。
・ポーターのファイブフォース分析により、バイヤーとサプライヤーの潜在力を明らかにし、ステークホルダーが利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるようにします。
・医療用転写ソフトウェア市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
・各地域の主要国を世界市場への収益貢献度に応じてマッピングしています。
・市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
・地域別および世界の医療用転写ソフトウェア市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析を含みます。

〈主要市場セグメント〉
展開別
クラウドベース
オンプレミス

種類別
音声キャプチャ
音声認識

エンドユーザー施設別
病院・クリニック
診断センター
その他

地域別
・北米
米国
カナダ
メキシコ
・ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
その他のヨーロッパ
・アジア太平洋
中国
日本
インド
オーストラリア
韓国
その他のアジア太平洋地域
・LAMEA
ブラジル
サウジアラビア
南アフリカ
その他のLAMEA地域

〈主要市場プレイヤー〉
3M Company
Amazon Inc
Aquity Solutions
DeepScribe, Inc.
Dolbey System, Inc.
Global Medical Transcription
iMedX
Microsoft Corporation
SMARTMD
ZyDoc Medical Transcription

世界の市場調査レポート販売サイト(H&Iグローバルリサーチ株式会社運営)
*** レポート目次(コンテンツ)***

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY DEPLOYMENT
4.1 Overview
4.1.1 Market size and forecast
4.2 Cloud Based
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 On Premises
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY TYPE
5.1 Overview
5.1.1 Market size and forecast
5.2 Voice Capture
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Voice Recognition
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
CHAPTER 6: MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY END USER FACILITIES
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospitals and Clinics
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.2.4 Hospitals and Clinics Medical Transcription Software Market by Type
6.2.4.1 Private Market size and forecast, by region
6.2.4.2 Public Market size and forecast, by region
6.3 Diagnostic Centers
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Others
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
CHAPTER 7: MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Deployment
7.2.3 North America Market size and forecast, by Type
7.2.4 North America Market size and forecast, by End User Facilities
7.2.4.1 North America Hospitals and Clinics Medical Transcription Software Market by Type
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Deployment
7.2.5.1.2 Market size and forecast, by Type
7.2.5.1.3 Market size and forecast, by End User Facilities
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Deployment
7.2.5.2.2 Market size and forecast, by Type
7.2.5.2.3 Market size and forecast, by End User Facilities
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Deployment
7.2.5.3.2 Market size and forecast, by Type
7.2.5.3.3 Market size and forecast, by End User Facilities
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Deployment
7.3.3 Europe Market size and forecast, by Type
7.3.4 Europe Market size and forecast, by End User Facilities
7.3.4.1 Europe Hospitals and Clinics Medical Transcription Software Market by Type
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Deployment
7.3.5.1.2 Market size and forecast, by Type
7.3.5.1.3 Market size and forecast, by End User Facilities
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Deployment
7.3.5.2.2 Market size and forecast, by Type
7.3.5.2.3 Market size and forecast, by End User Facilities
7.3.5.3 UK
7.3.5.3.1 Market size and forecast, by Deployment
7.3.5.3.2 Market size and forecast, by Type
7.3.5.3.3 Market size and forecast, by End User Facilities
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Deployment
7.3.5.4.2 Market size and forecast, by Type
7.3.5.4.3 Market size and forecast, by End User Facilities
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Deployment
7.3.5.5.2 Market size and forecast, by Type
7.3.5.5.3 Market size and forecast, by End User Facilities
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Deployment
7.3.5.6.2 Market size and forecast, by Type
7.3.5.6.3 Market size and forecast, by End User Facilities
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Deployment
7.4.3 Asia-Pacific Market size and forecast, by Type
7.4.4 Asia-Pacific Market size and forecast, by End User Facilities
7.4.4.1 Asia-Pacific Hospitals and Clinics Medical Transcription Software Market by Type
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Market size and forecast, by Deployment
7.4.5.1.2 Market size and forecast, by Type
7.4.5.1.3 Market size and forecast, by End User Facilities
7.4.5.2 Japan
7.4.5.2.1 Market size and forecast, by Deployment
7.4.5.2.2 Market size and forecast, by Type
7.4.5.2.3 Market size and forecast, by End User Facilities
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Deployment
7.4.5.3.2 Market size and forecast, by Type
7.4.5.3.3 Market size and forecast, by End User Facilities
7.4.5.4 Australia
7.4.5.4.1 Market size and forecast, by Deployment
7.4.5.4.2 Market size and forecast, by Type
7.4.5.4.3 Market size and forecast, by End User Facilities
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Deployment
7.4.5.5.2 Market size and forecast, by Type
7.4.5.5.3 Market size and forecast, by End User Facilities
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Market size and forecast, by Deployment
7.4.5.6.2 Market size and forecast, by Type
7.4.5.6.3 Market size and forecast, by End User Facilities
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Deployment
7.5.3 LAMEA Market size and forecast, by Type
7.5.4 LAMEA Market size and forecast, by End User Facilities
7.5.4.1 LAMEA Hospitals and Clinics Medical Transcription Software Market by Type
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Deployment
7.5.5.1.2 Market size and forecast, by Type
7.5.5.1.3 Market size and forecast, by End User Facilities
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Deployment
7.5.5.2.2 Market size and forecast, by Type
7.5.5.2.3 Market size and forecast, by End User Facilities
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Deployment
7.5.5.3.2 Market size and forecast, by Type
7.5.5.3.3 Market size and forecast, by End User Facilities
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Deployment
7.5.5.4.2 Market size and forecast, by Type
7.5.5.4.3 Market size and forecast, by End User Facilities
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 3M Company
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Amazon Inc
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Aquity Solutions
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 DeepScribe, Inc.
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Dolbey System, Inc.
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Global Medical Transcription
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 iMedX
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Microsoft Corporation
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 SMARTMD
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 ZyDoc Medical Transcription
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
TABLE 2. MEDICAL TRANSCRIPTION SOFTWARE MARKET, FOR CLOUD BASED, BY REGION, 2021-2031 ($MILLION)
TABLE 3. MEDICAL TRANSCRIPTION SOFTWARE MARKET FOR CLOUD BASED, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. MEDICAL TRANSCRIPTION SOFTWARE MARKET, FOR ON PREMISES, BY REGION, 2021-2031 ($MILLION)
TABLE 5. MEDICAL TRANSCRIPTION SOFTWARE MARKET FOR ON PREMISES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 6. GLOBAL MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 7. MEDICAL TRANSCRIPTION SOFTWARE MARKET, FOR VOICE CAPTURE, BY REGION, 2021-2031 ($MILLION)
TABLE 8. MEDICAL TRANSCRIPTION SOFTWARE MARKET FOR VOICE CAPTURE, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 9. MEDICAL TRANSCRIPTION SOFTWARE MARKET, FOR VOICE RECOGNITION, BY REGION, 2021-2031 ($MILLION)
TABLE 10. MEDICAL TRANSCRIPTION SOFTWARE MARKET FOR VOICE RECOGNITION, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 11. GLOBAL MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY END USER FACILITIES, 2021-2031 ($MILLION)
TABLE 12. MEDICAL TRANSCRIPTION SOFTWARE MARKET, FOR HOSPITALS AND CLINICS, BY REGION, 2021-2031 ($MILLION)
TABLE 13. MEDICAL TRANSCRIPTION SOFTWARE MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 14. GLOBAL HOSPITALS AND CLINICS MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 15. MEDICAL TRANSCRIPTION SOFTWARE MARKET, FOR PRIVATE, BY REGION, 2021-2031 ($MILLION)
TABLE 16. MEDICAL TRANSCRIPTION SOFTWARE MARKET, FOR PUBLIC, BY REGION, 2021-2031 ($MILLION)
TABLE 17. MEDICAL TRANSCRIPTION SOFTWARE MARKET, FOR DIAGNOSTIC CENTERS, BY REGION, 2021-2031 ($MILLION)
TABLE 18. MEDICAL TRANSCRIPTION SOFTWARE MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 19. MEDICAL TRANSCRIPTION SOFTWARE MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 20. MEDICAL TRANSCRIPTION SOFTWARE MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 21. MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 22. NORTH AMERICA MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
TABLE 23. NORTH AMERICA MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 24. NORTH AMERICA MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY END USER FACILITIES, 2021-2031 ($MILLION)
TABLE 25. NORTH AMERICA HOSPITALS AND CLINICS MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 26. NORTH AMERICA MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 27. U.S. MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
TABLE 28. U.S. MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 29. U.S. MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY END USER FACILITIES, 2021-2031 ($MILLION)
TABLE 30. CANADA MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
TABLE 31. CANADA MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 32. CANADA MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY END USER FACILITIES, 2021-2031 ($MILLION)
TABLE 33. MEXICO MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
TABLE 34. MEXICO MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 35. MEXICO MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY END USER FACILITIES, 2021-2031 ($MILLION)
TABLE 36. EUROPE MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
TABLE 37. EUROPE MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 38. EUROPE MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY END USER FACILITIES, 2021-2031 ($MILLION)
TABLE 39. EUROPE HOSPITALS AND CLINICS MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 40. EUROPE MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 41. GERMANY MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
TABLE 42. GERMANY MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 43. GERMANY MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY END USER FACILITIES, 2021-2031 ($MILLION)
TABLE 44. FRANCE MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
TABLE 45. FRANCE MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 46. FRANCE MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY END USER FACILITIES, 2021-2031 ($MILLION)
TABLE 47. UK MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
TABLE 48. UK MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 49. UK MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY END USER FACILITIES, 2021-2031 ($MILLION)
TABLE 50. ITALY MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
TABLE 51. ITALY MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 52. ITALY MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY END USER FACILITIES, 2021-2031 ($MILLION)
TABLE 53. SPAIN MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
TABLE 54. SPAIN MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 55. SPAIN MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY END USER FACILITIES, 2021-2031 ($MILLION)
TABLE 56. REST OF EUROPE MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
TABLE 57. REST OF EUROPE MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 58. REST OF EUROPE MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY END USER FACILITIES, 2021-2031 ($MILLION)
TABLE 59. ASIA-PACIFIC MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
TABLE 60. ASIA-PACIFIC MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 61. ASIA-PACIFIC MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY END USER FACILITIES, 2021-2031 ($MILLION)
TABLE 62. ASIA-PACIFIC HOSPITALS AND CLINICS MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 63. ASIA-PACIFIC MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 64. CHINA MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
TABLE 65. CHINA MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 66. CHINA MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY END USER FACILITIES, 2021-2031 ($MILLION)
TABLE 67. JAPAN MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
TABLE 68. JAPAN MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 69. JAPAN MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY END USER FACILITIES, 2021-2031 ($MILLION)
TABLE 70. INDIA MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
TABLE 71. INDIA MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 72. INDIA MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY END USER FACILITIES, 2021-2031 ($MILLION)
TABLE 73. AUSTRALIA MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
TABLE 74. AUSTRALIA MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 75. AUSTRALIA MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY END USER FACILITIES, 2021-2031 ($MILLION)
TABLE 76. SOUTH KOREA MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
TABLE 77. SOUTH KOREA MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 78. SOUTH KOREA MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY END USER FACILITIES, 2021-2031 ($MILLION)
TABLE 79. REST OF ASIA-PACIFIC MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
TABLE 80. REST OF ASIA-PACIFIC MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 81. REST OF ASIA-PACIFIC MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY END USER FACILITIES, 2021-2031 ($MILLION)
TABLE 82. LAMEA MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
TABLE 83. LAMEA MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 84. LAMEA MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY END USER FACILITIES, 2021-2031 ($MILLION)
TABLE 85. LAMEA HOSPITALS AND CLINICS MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 86. LAMEA MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 87. BRAZIL MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
TABLE 88. BRAZIL MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 89. BRAZIL MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY END USER FACILITIES, 2021-2031 ($MILLION)
TABLE 90. SAUDI ARABIA MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
TABLE 91. SAUDI ARABIA MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 92. SAUDI ARABIA MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY END USER FACILITIES, 2021-2031 ($MILLION)
TABLE 93. SOUTH AFRICA MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
TABLE 94. SOUTH AFRICA MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 95. SOUTH AFRICA MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY END USER FACILITIES, 2021-2031 ($MILLION)
TABLE 96. REST OF LAMEA MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
TABLE 97. REST OF LAMEA MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 98. REST OF LAMEA MEDICAL TRANSCRIPTION SOFTWARE MARKET, BY END USER FACILITIES, 2021-2031 ($MILLION)
TABLE 99.3M COMPANY: COMPANY SNAPSHOT
TABLE 100.3M COMPANY: OPERATING SEGMENTS
TABLE 101.3M COMPANY: PRODUCT PORTFOLIO
TABLE 102.3M COMPANY: NET SALES,
TABLE 103.3M COMPANY: KEY STRATERGIES
TABLE 104.AMAZON INC: COMPANY SNAPSHOT
TABLE 105.AMAZON INC: OPERATING SEGMENTS
TABLE 106.AMAZON INC: PRODUCT PORTFOLIO
TABLE 107.AMAZON INC: NET SALES,
TABLE 108.AMAZON INC: KEY STRATERGIES
TABLE 109.AQUITY SOLUTIONS: COMPANY SNAPSHOT
TABLE 110.AQUITY SOLUTIONS: OPERATING SEGMENTS
TABLE 111.AQUITY SOLUTIONS: PRODUCT PORTFOLIO
TABLE 112.AQUITY SOLUTIONS: NET SALES,
TABLE 113.AQUITY SOLUTIONS: KEY STRATERGIES
TABLE 114.DEEPSCRIBE, INC.: COMPANY SNAPSHOT
TABLE 115.DEEPSCRIBE, INC.: OPERATING SEGMENTS
TABLE 116.DEEPSCRIBE, INC.: PRODUCT PORTFOLIO
TABLE 117.DEEPSCRIBE, INC.: NET SALES,
TABLE 118.DEEPSCRIBE, INC.: KEY STRATERGIES
TABLE 119.DOLBEY SYSTEM, INC.: COMPANY SNAPSHOT
TABLE 120.DOLBEY SYSTEM, INC.: OPERATING SEGMENTS
TABLE 121.DOLBEY SYSTEM, INC.: PRODUCT PORTFOLIO
TABLE 122.DOLBEY SYSTEM, INC.: NET SALES,
TABLE 123.DOLBEY SYSTEM, INC.: KEY STRATERGIES
TABLE 124.GLOBAL MEDICAL TRANSCRIPTION: COMPANY SNAPSHOT
TABLE 125.GLOBAL MEDICAL TRANSCRIPTION: OPERATING SEGMENTS
TABLE 126.GLOBAL MEDICAL TRANSCRIPTION: PRODUCT PORTFOLIO
TABLE 127.GLOBAL MEDICAL TRANSCRIPTION: NET SALES,
TABLE 128.GLOBAL MEDICAL TRANSCRIPTION: KEY STRATERGIES
TABLE 129.IMEDX: COMPANY SNAPSHOT
TABLE 130.IMEDX: OPERATING SEGMENTS
TABLE 131.IMEDX: PRODUCT PORTFOLIO
TABLE 132.IMEDX: NET SALES,
TABLE 133.IMEDX: KEY STRATERGIES
TABLE 134.MICROSOFT CORPORATION: COMPANY SNAPSHOT
TABLE 135.MICROSOFT CORPORATION: OPERATING SEGMENTS
TABLE 136.MICROSOFT CORPORATION: PRODUCT PORTFOLIO
TABLE 137.MICROSOFT CORPORATION: NET SALES,
TABLE 138.MICROSOFT CORPORATION: KEY STRATERGIES
TABLE 139.SMARTMD: COMPANY SNAPSHOT
TABLE 140.SMARTMD: OPERATING SEGMENTS
TABLE 141.SMARTMD: PRODUCT PORTFOLIO
TABLE 142.SMARTMD: NET SALES,
TABLE 143.SMARTMD: KEY STRATERGIES
TABLE 144.ZYDOC MEDICAL TRANSCRIPTION: COMPANY SNAPSHOT
TABLE 145.ZYDOC MEDICAL TRANSCRIPTION: OPERATING SEGMENTS
TABLE 146.ZYDOC MEDICAL TRANSCRIPTION: PRODUCT PORTFOLIO
TABLE 147.ZYDOC MEDICAL TRANSCRIPTION: NET SALES,
TABLE 148.ZYDOC MEDICAL TRANSCRIPTION: KEY STRATERGIES

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(ALD23FB264 )"医療用転写ソフトウェアのグローバル市場(2021〜2031):クラウドベース、オンプレミス" (英文:Medical Transcription Software Market By Deployment (Cloud Based, On Premises), By Type (Voice Capture, Voice Recognition), By End User Facilities (Hospitals and Clinics, Diagnostic Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031)はAllied Market Research社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。